Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 9, Issue 8, Pages 565-573
Publisher
SAGE Publications
Online
2017-07-12
DOI
10.1177/1758834017719215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer
- (2017) Benjamin A. Teply et al. EUROPEAN UROLOGY
- Germline DNA Repair Mutations and Response to Hormonal Therapy in Advanced Prostate Cancer
- (2017) Emmanuel S. Antonarakis EUROPEAN UROLOGY
- Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
- (2017) Matti Annala et al. EUROPEAN UROLOGY
- DNA Repair in Prostate Cancer: Biology and Clinical Implications
- (2017) Joaquin Mateo et al. EUROPEAN UROLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate
- (2017) Tilman Todenhöfer et al. JOURNAL OF UROLOGY
- Liquid biopsy: ready to guide therapy in advanced prostate cancer?
- (2016) Miriam Hegemann et al. BJU INTERNATIONAL
- Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
- (2016) Takashi Kawahara et al. BMC CANCER
- Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer
- (2016) Takahiro Inoue et al. Clinical Genitourinary Cancer
- Sequencing Treatment for Castration-Resistant Prostate Cancer
- (2016) Catherine E. Handy et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer
- (2016) Heather H. Cheng et al. EUROPEAN UROLOGY
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study
- (2016) Naoki Terada et al. International Journal of Clinical Oncology
- Blood Based Detection of Androgen Receptor Splice Variants in Patients with Advanced Prostate Cancer
- (2016) Emmanuel S. Antonarakis et al. JOURNAL OF UROLOGY
- A Whole Blood Assay for AR-V7 and ARv567es in Patients with Prostate Cancer
- (2016) Xichun Liu et al. JOURNAL OF UROLOGY
- Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy
- (2016) Zhenfei Li et al. NATURE
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
- (2016) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer
- (2016) John L. Silberstein et al. Current Urology Reports
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Serial blood-based analysis of AR-V7 in men with advanced prostate cancer
- (2015) M. Nakazawa et al. ANNALS OF ONCOLOGY
- Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients
- (2015) Diana H. Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
- (2015) Benjamin L. Maughan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
- (2015) Wendy Onstenk et al. EUROPEAN UROLOGY
- PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
- (2015) Roberta Ferraldeschi et al. EUROPEAN UROLOGY
- Sequencing of agents in castration-resistant prostate cancer
- (2015) David Lorente et al. LANCET ONCOLOGY
- Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
- (2015) Sujata Narayanan et al. Nature Reviews Urology
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer
- (2015) Takayuki Goto et al. PROSTATE
- Liquid biopsy: Clues on prostate cancer drug resistance
- (2015) Michael T. Schweizer et al. Science Translational Medicine
- Plasma AR and abiraterone-resistant prostate cancer
- (2015) Alessandro Romanel et al. Science Translational Medicine
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Correlation of Sprouty1 and Jagged1 With Aggressive Prostate Cancer Cells With Different Sensitivities to Androgen Deprivation
- (2014) Naoki Terada et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2014) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer in Asian men
- (2014) Kazuto Ito Nature Reviews Urology
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
- (2014) Christina Hägglöf et al. PLoS One
- The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer
- (2014) Takayuki Goto et al. PLoS One
- The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer
- (2014) Kenji Nakayama et al. PLoS One
- Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
- (2014) Mary Nakazawa et al. Hormones & Cancer
- Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
- (2013) K. A. Leinonen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- The Mutational Landscape of Prostate Cancer
- (2013) Christopher E. Barbieri et al. EUROPEAN UROLOGY
- Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
- (2013) Takashi Kobayashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum Androgens As Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results From an Analysis of a Randomized Phase III Trial
- (2013) Charles J. Ryan et al. JOURNAL OF CLINICAL ONCOLOGY
- An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
- (2013) M. Korpal et al. Cancer Discovery
- Cyr61 is a potential prognostic marker for prostate cancer
- (2012) Naoki Terada et al. ASIAN JOURNAL OF ANDROLOGY
- The role of proteomics in prostate cancer research: Biomarker discovery and validation
- (2012) Elisa Pin et al. CLINICAL BIOCHEMISTRY
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- (2011) Carmen Jerónimo et al. EUROPEAN UROLOGY
- TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
- (2011) Daniel C. Danila et al. EUROPEAN UROLOGY
- Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness
- (2011) Naoki Terada et al. PROSTATE
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
- (2010) N. Terada et al. CANCER RESEARCH
- Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
- (2010) K. A. Leinonen et al. CLINICAL CANCER RESEARCH
- Predictive and prognostic molecular markers for cancer medicine
- (2010) Sunali Mehta et al. Therapeutic Advances in Medical Oncology
- Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
- (2009) G. Attard et al. CANCER RESEARCH
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer
- (2009) Joost L. Boormans et al. EUROPEAN UROLOGY
- An Update of the Gleason Grading System
- (2009) Jonathan I. Epstein JOURNAL OF UROLOGY
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now